AMRX amneal.com: Rasio nilai perusahaan marang pendapatan

Amneal Pharmaceuticals, Inc. (AMRX) - logo korporat

The company's price-to-sales ratio reflects the market consensus, where 3339.88 serves as the final level marker. Amneal Pharmaceuticals (AMRX) relies on a warehouse network and strict quality control to drive supply efficiency. The business is shifting its focus toward high-cost biosimilars and injectables, reducing the share of simple tablets. A stable economic moat is maintained through US-based production and compliance with rigorous industry standards.

Amneal Pharmaceuticals Inc (AMRX): Multiplikator EV/Sales saka 23.11.2025 nganti 20.11.2026

Rincian metrik keuangan lan pasar Amneal Pharmaceuticals Inc (AMRX)

- nilai pasar lan prakiraan target analis:
- indikator dhuwit lan arus kas:
Analisis wiwitan perusahaan:Amneal Pharmaceuticals
Barang unggulan Amneal Pharmaceuticals, Inc.

Risks of substance shortages from Asia and logistics disruptions at Amneal Pharmaceuticals (AMRX) directly impact revenue volumes, making the EV/Sales calculation critical for assessing business value regardless of debt load. This ratio compares the total enterprise value to its sales, allowing the historical EV/Sales trend to determine whether the current discount results from undervaluation or a systemic decline of the asset.

Analisis pesaing Amneal Pharmaceuticals

HLN: Rasio nilai perusahaan marang pendapatan|Kenvue Corp (KVUE) - Rasio nilai perusahaan marang pendapatan|Verona Pharma PLC - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Jyong Biotech Ltd|Multiplikator EV/Sales Ligand Corp|Multiplikator EV/Sales PRGO|Koefisien nilai perusahaan marang pendapatan ALVO|Multiplikator EV/Sales LQDA (Liquidia Technologies)|Multiplikator EV/Sales Galapagos GLPG|ANI Pharmaceuticals Inc - Multiplikator EV/Sales|MNKD (MannKind Corp.) - Rasio nilai perusahaan marang pendapatan|AMPH: Multiplikator EV/Sales|PCRX (Pacira BioSciences) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan ARS Pharmaceuticals Inc|Nilai perusahaan marang pendapatan Theravance Biopharma, Inc. (TBPH)|Nilai perusahaan marang pendapatan AQST (Aquestive Pharma)|SCPH - Multiplikator nilai perusahaan marang pendapatan|Multiplikator EV/Sales TECX (Tectonic Therapeutic, Inc.)|TNXP - Nilai perusahaan marang pendapatan|China SXT Pharmaceuticals, Inc. - Multiplikator EV/Sales|EPRX - Multiplikator EV/Sales|BHST: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan eXoZymes Inc (EXOZ)|ORMP (oramed.com) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan ENTX (Entera Bio)|Rasio nilai perusahaan marang pendapatan MindWalk (HYFT)|Multiplikator EV/Sales ABVC BioPharma, Inc. (ABVC)|Rasio nilai perusahaan marang pendapatan Cumberland Corp CPIX|QNTM - Nilai perusahaan marang pendapatan|FGEN - Rasio nilai perusahaan marang pendapatan|TELO - Multiplikator EV/Sales|Rani Therapeutics Inc (RANI) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan SNYR|Rasio nilai perusahaan marang pendapatan Rallybio Corp|Rasio nilai perusahaan marang pendapatan LEXX|Multiplikator EV/Sales PULM|PTHL: Nilai perusahaan marang volume dodolan|Multiplikator EV/Sales APM (Aptorum Group Ltd)|LYRA - Nilai perusahaan marang pendapatan|Impact BioMedical Inc - Multiplikator EV/Sales|Nilai perusahaan marang volume dodolan TNFA|YCBD (cbdmd.com) - Nilai perusahaan marang pendapatan|painreform.com - Nilai bisnis marang pendapatan|Nilai perusahaan marang pendapatan CYTO|Rasio nilai perusahaan marang pendapatan LIPO|Rasio nilai perusahaan marang pendapatan optinose.com (OPTN)|PIRS (Pieris Pharma) - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Procaps Group S.A. PROC|Rasio total nilai perusahaan marang pendapatan petrospharma.com (PTPI)|QLI - Rasio nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan SLRN (ACELYRIN)|TFF Pharmaceuticals, Inc (TFFP) - Rasio nilai perusahaan marang pendapatan